chr20-10295573-A-T
Variant names: 
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_130811.4(SNAP25):c.282-1352A>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.232 in 151,966 control chromosomes in the GnomAD database, including 4,447 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
 Genomes: 𝑓 0.23   (  4447   hom.,  cov: 32) 
Consequence
 SNAP25
NM_130811.4 intron
NM_130811.4 intron
Scores
 2
Clinical Significance
 Not reported in ClinVar 
Conservation
 PhyloP100:  1.15  
Publications
8 publications found 
Genes affected
 SNAP25  (HGNC:11132):  (synaptosome associated protein 25) Synaptic vesicle membrane docking and fusion is mediated by SNAREs (soluble N-ethylmaleimide-sensitive factor attachment protein receptors) located on the vesicle membrane (v-SNAREs) and the target membrane (t-SNAREs). The assembled v-SNARE/t-SNARE complex consists of a bundle of four helices, one of which is supplied by v-SNARE and the other three by t-SNARE. For t-SNAREs on the plasma membrane, the protein syntaxin supplies one helix and the protein encoded by this gene contributes the other two. Therefore, this gene product is a presynaptic plasma membrane protein involved in the regulation of neurotransmitter release. Two alternative transcript variants encoding different protein isoforms have been described for this gene. [provided by RefSeq, Jul 2008] 
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81). 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.284  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.232  AC: 35258AN: 151846Hom.:  4447  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
35258
AN: 
151846
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.232  AC: 35265AN: 151966Hom.:  4447  Cov.: 32 AF XY:  0.232  AC XY: 17194AN XY: 74258 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
35265
AN: 
151966
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
17194
AN XY: 
74258
show subpopulations 
African (AFR) 
 AF: 
AC: 
6127
AN: 
41450
American (AMR) 
 AF: 
AC: 
3136
AN: 
15280
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1093
AN: 
3466
East Asian (EAS) 
 AF: 
AC: 
561
AN: 
5140
South Asian (SAS) 
 AF: 
AC: 
1104
AN: 
4816
European-Finnish (FIN) 
 AF: 
AC: 
2864
AN: 
10538
Middle Eastern (MID) 
 AF: 
AC: 
97
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
19517
AN: 
67966
Other (OTH) 
 AF: 
AC: 
494
AN: 
2108
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1369 
 2738 
 4108 
 5477 
 6846 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 382 
 764 
 1146 
 1528 
 1910 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
553
AN: 
3478
ClinVar
Not reported inComputational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.